Kontigo Care (KONT) Q2 2026 earnings summary

Executive summary

• Revenue for Q2 2026 was 7.2 MSEK, up 1.8% year-over-year, with stable income and continued cost discipline.

• EBITDA (excluding capitalized development costs) turned positive at 0.8 MSEK, reflecting improved underlying profitability.

• The company is preparing for international expansion, notably in the US, and is set to launch Previct® Safety targeting workplace risk prevention.

Financial highlights

• Monthly recurring revenue (MRR) at quarter-end was 2.35 MSEK, flat sequentially and down 0.8% year-over-year.

• Net sales for H1 2026 reached 14.5 MSEK, up 3.1% year-over-year.

• EBITDA (excl. capitalized dev. costs) for H1 was 1.9 MSEK (margin 12.8%), up from -3.6 MSEK.

• EBIT for Q2 was -1.1 MSEK (margin -14.9%), improved from -1.4 MSEK.

• Net result for Q2 was -1.0 MSEK, or -0.03 SEK per share.

Outlook and guidance

• Focus remains on profitable growth, US market entry, and the launch of Previct® Safety in H2 2026.

• No formal financial forecasts have been issued.